Predictors of early mortality after heart transplantation: The Canadian transplant experience from 1981 to 1992

Canadian Journal of Cardiology

Volumn 14, Issue 5, 1998, Pages 703-707

  Carrier, Michel ^a,e   Rivard, Michèle ^b   Latter, David ^c   Kostuk, William ^d  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e NONE   (Canada)

Author keywords

Heart transplantation; Pulmonary hypertension

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD GROUP; BODY MASS; CANADA; FEMALE; HEART TRANSPLANTATION; HUMAN; LUNG PRESSURE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; ORGAN DONOR; RETROSPECTIVE STUDY; RISK FACTOR;

ADOLESCENT; ADULT; CANADA; CAUSE OF DEATH; FEMALE; HEART TRANSPLANTATION; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PULMONARY WEDGE PRESSURE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TISSUE DONORS; VASCULAR RESISTANCE;

EID: 0031861163     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Murali S, Kormos RL, Uretsky BF, et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J 1993;126:896-904.
2. Ibrahim M, Master RG, Hendry PJ, et al. Determinants of hospital survival after cardiac transplantation. Ann Thorac Surg 1995;59:604-8.
3. Bourge RC, Naftel DC, Constanzo-Nordin MR, et al. Pretransplantation risk factors for death after heart transplantation: a multiinstitution study. The Transplant Cardiologists Research Database Group. J Heart Lung Transplant 1993;12:49-62.
4. Kirklin JK, Naftel DC, Kirklin JW, Blackstone EH, White-Williams C, Bourge RC. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant 1988;7:331-6.
5. Sarris GE, Moore KA, Schroeder JS, et al. Cardiac transplantation: the Stanford experience in the cyclosporine era. J Thorac Cardiovasc Surg 1994;108:240-51.
6. Bourge RC, Kirklin JK, Naftel DC, White C, Mason DA, Epstein AE. Analysis and predictors of pulmonary vascular resistance after cardiac transplantation. J Thorac Cardiovasc Surg 1991;101:432-44.
7. Chau EM, Bailey KR, Mahoney DW, et al. Predictors of reversibility of pulmonary hypertension in cardiac transplant recipients in the first postoperative year. Circulation 1996;94(9 Suppl):II267-72.
8. Simonsen S, Molstad P, Geiran O, Froysaker T. Heart transplantation in patients with severe pulmonary hypertension and increased pulmonary vascular resistance. Scand J Thorac Cardiovasc Surg 1990;24:161-4.
9. Grant SC, Levy RD, Brooks NH. Fall in pulmonary vascular resistance in patients awaiting heart transplantation. Br Heart J 1992;68:365-8.
10. Menkis AH, Novick RJ, Kostuk WJ, et al. Successful use of the "unacceptable" heart donor. J Heart Lung Transplant 1991;10:28-32.
11. Jeevanandam V, Furukawa S, Pendergast TW, Todd BA, Eisen HJ, McClurken JB. Standard criteria for an acceptable donor heart are restricting heart transplantation. Ann Thorac Surg 1996;62:1268-75.
12. Young JB, Naftel DC, Bourge RC, et al. Matching the heart donor and heart transplant recipient. Clues for successful expansion of the donor pool: a multivariate, multiinstitutional report. The Cardiac Transplant Research Database Group. J Heart Lung Transplant 1994;13:353-65.
13. The US Scientific Registry of Transplant Recipients. 1996 Annual Report.
14. Canadian Registry of Organ Replacement. 1996 Annual Report.
15. Rao V, Feindel CM, Weisel RD, Boylen P, Cohen G. Donor blood perfusion improves myocardial recovery after heart transplantation. J Heart Lung Transplant 1997;16:667-73.